NICE launches consultation on new Quality and Outcomes Framework
20 new potential QOF indicators proposed
Tuesday, 10 January 2012
Many new indicators of good health and good care are being proposed as part of next year’s Quality and Outcomes Framework (QOF) for GPs.
NICE has published its proposed QOF indicators for 2013-14, which contain 20 new indicators across 10 domains, as part of a four-week public consultation.
Doctors, the public and any interested parties are being invited to comment on the proposed indicators that will form the voluntary incentive scheme for GP practices that rewards GPs for how well they care for patients.
The 20 potential new indicators cover 10 domains:
- chronic obstructive pulmonary disease
- heart failure
- secondary prevention of coronary heart disease (CHD)
- diabetes: erectile dysfunction
- diabetes: lipid management
- rheumatoid arthritis
The indicators were developed following recommendations from QOF committee meetings, and indicators have been or are currently being piloted in representative practices across the UK to test their feasibility and acceptability.
NICE said the QOF advisory committee would consider results of the piloting and feedback from the consultation in June before recommending which of these potential indicators should be included in next year’s QOF menu.
NHS Employers and the BMA’s GP committee will then decide which indicators will be included within the 2013-14 QOF.
Dr Fergus Macbeth, director of the centre for clinical practice at NICE, said: “This consultation on potential new indicators is an integral part of NICE's process for QOF. It provides the opportunity for anyone to contribute to the development of indicators for the 2013-14 Quality Outcomes Framework.
“We value this input highly and any feedback will help the QOF advisory committee decide which indicators will be put forward for publication on the NICE menu for the QOF.
“The final menu of indicators, to be published on the NICE website in August, will support healthcare professionals to deliver good quality patient care, based on the best available evidence.”
The consultation ends on 6 February.